Stock 511523 VEERHEALTH CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Veerhealth Care Limited

Equities

511523

INE882C01035

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-05-03 am EDT 		5-day change 1st Jan Change
20.01 INR -1.96% Intraday chart for Veerhealth Care Limited -6.06% -1.82%
Apr. 02 Veerhealth Care Bags Order Worth Nearly INR6 Million from Apollo Healthco MT
Apr. 01 Veerhealth Care Limited Receives Order from M/S. Apollo Healthco Limited CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 86.68 52.01 44.03 52.7 79.26 200.5
Enterprise Value (EV) 1 98.02 59.58 68.64 69 75.22 164.4
P/E ratio 63.2 x 32.9 x 13.8 x 13.9 x -104 x 12.7 x
Yield - - - - - -
Capitalization / Revenue 1.68 x 0.87 x 0.38 x 0.46 x 0.73 x 1.41 x
EV / Revenue 1.9 x 1 x 0.59 x 0.61 x 0.7 x 1.16 x
EV / EBITDA -79.1 x 13.5 x 10.1 x 8.05 x 21.3 x 11.4 x
EV / FCF -4.02 x 1.63 x -3.2 x -23 x 8.12 x -4.91 x
FCF Yield -24.9% 61.5% -31.3% -4.35% 12.3% -20.4%
Price to Book 0.66 x 0.39 x 0.32 x 0.38 x 0.57 x 0.94 x
Nbr of stocks (in thousands) 13,868 13,868 13,868 13,868 13,868 19,998
Reference price 2 6.250 3.750 3.175 3.800 5.715 10.02
Announcement Date 8/27/18 8/27/19 9/5/20 8/31/21 9/2/22 8/19/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 51.69 59.84 117.3 113.7 108 142.1
EBITDA 1 -1.239 4.413 6.788 8.567 3.526 14.44
EBIT 1 -3.987 1.213 3.556 3.885 -1.716 8.221
Operating Margin -7.71% 2.03% 3.03% 3.42% -1.59% 5.78%
Earnings before Tax (EBT) 1 2.506 3.786 6.469 5.767 2.376 11.17
Net income 1 1.371 1.583 3.183 3.792 -0.736 15.82
Net margin 2.65% 2.65% 2.71% 3.34% -0.68% 11.13%
EPS 2 0.0989 0.1141 0.2295 0.2734 -0.0550 0.7911
Free Cash Flow 1 -24.38 36.63 -21.45 -3 9.264 -33.47
FCF margin -47.17% 61.21% -18.29% -2.64% 8.58% -23.55%
FCF Conversion (EBITDA) - 830.08% - - 262.74% -
FCF Conversion (Net income) - 2,314.06% - - - -
Dividend per Share - - - - - -
Announcement Date 8/27/18 8/27/19 9/5/20 8/31/21 9/2/22 8/19/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 11.3 7.58 24.6 16.3 - -
Net Cash position 1 - - - - 4.04 36.1
Leverage (Debt/EBITDA) -9.155 x 1.717 x 3.626 x 1.903 x - -
Free Cash Flow 1 -24.4 36.6 -21.5 -3 9.26 -33.5
ROE (net income / shareholders' equity) 1.06% 1.2% 2.35% 2.73% -0.53% 8.94%
ROA (Net income/ Total Assets) -1.79% 0.49% 1.3% 1.32% -0.55% 2.26%
Assets 1 -76.47 322.7 244.5 286.7 133.4 699
Book Value Per Share 2 9.450 9.580 9.920 10.10 10.10 10.70
Cash Flow per Share 2 0.0600 0.1300 0.0100 0.0700 0.2900 1.810
Capex 1 35.4 21.9 21.2 4.98 15.8 20.9
Capex / Sales 68.39% 36.54% 18.12% 4.38% 14.67% 14.68%
Announcement Date 8/27/18 8/27/19 9/5/20 8/31/21 9/2/22 8/19/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
VEERHEALTH CARE LIMITED Stock Veerhealth Care Limited
-1.82% 7.2M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 511523 Stock
  4. Financials Veerhealth Care Limited